Suspended

Magnesium Sulfate Versus Indomethacin for Preterm Labor

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Urogenital Diseases+2

+ Female Urogenital Diseases and Pregnancy Complications

+ Obstetric Labor Complications

+16 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Phase 4
Interventional
Study Start: February 2003
See protocol details

Summary

Principal SponsorUniversity of Pennsylvania
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2003

Actual date on which the first participant was enrolled.

The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, will decrease the proportion of neonates diagnosed with major complications or death.

Official TitleMagnesium Sulfate Versus Indomethacin for Preterm Labor
Principal SponsorUniversity of Pennsylvania
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsObstetric Labor ComplicationsObstetric Labor, PrematurePregnancy Complications

Criteria

5 inclusion criteria required to participate
Initial episode of preterm labor for enrollment

The diagnosis of preterm labor

Gestational age between 24 and 32 weeks

Singleton or twin gestation

Show More Criteria

11 exclusion criteria prevent from participating
Cervical dilation >5 cms

Suspected chorioamnionitis

Fetal distress

Vaginal bleeding

Show More Criteria

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

University of Pennsylvania

Philadelphia, United StatesOpen University of Pennsylvania in Google Maps
SuspendedOne Study Center